Proteinase K Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
Overview
Proteinase K Market is expected to reach USD 187.49 Mn. at a CAGR of 7.6 % during the forecast period 2032.
Proteinase K Market Introduction and Overview
Proteinase k is a subtilisin-like serine protease with a catalytic triad of Serine, Histidine, and Aspartic acid. It is a fungal protease isolated from the Engyodontium album. The enzyme has a broad application in Nucleic Acid extraction procedures. It is used to digest the proteins present and remove contamination. This ability of Proteinase k to digest proteins and its stability in SDS technique makes it important in a variety of techniques such as Fingerprinting, Protein purification and Removal of Chromosomal DNA for pulse-field electrophoresis.
To know about the Research Methodology :- Request Free Sample Report
Detection of COVID-19 virus via RT-qPCR has gained great importance during the pandemic. The RNA extraction step of the PCR protocol makes use of the Proteinase k enzyme which is a major driver in boosting the market. Also, increase in the number of chronic diseases, increasing Biotechnology industries, Advances in Molecular Biology and Drug-designing fields aid for the market to rise in the forecast period. Because of its crucial role in biological processes Proteinase k has great importance in the medical and pharmaceutical industries.
Availability of other protease enzymes and purity of available proteinase k in the market are some factors that may restrain the market from growing.
Proteinase K Market Competitive Landscape
The objective of the report is to present a comprehensive analysis of Global Proteinase K Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Proteinase K Market dynamics, structure by analyzing the market segments and project the Global Proteinase K Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Proteinase K Market make the report investor’s guide.
Proteinase K Market Segment Analysis
The powdered form segment of proteinase k dominated the market with a revenue of $xx Mn in 2025. Enzymes are highly sensitive to denaturation and oxidation processes. The powdered form allows easy physical isolation of enzymes in particles. Whereas, the isolation of enzymes in liquid form is difficult.As per the protocols, stock solutions are prepared using the powder form of enzymes. The powdered form of proteinase k is used widely because of its advantages over that of the liquid form. Powdered form enzymes have a prolonged shelf-life as compared to other forms and hence are used often.
Recent Industry Developments
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 14 January 2026 | ACROBiosystems | The company expanded its enzyme portfolio with high-purity recombinant Proteinase K specifically for automated diagnostic workflows. | This launch reduces processing time for high-throughput clinical labs by optimizing enzyme activity for robotics. |
| 02 November 2025 | Merck KGaA | Merck introduced a room-temperature stable lyophilized Proteinase K formulation to address global cold-chain logistics challenges. | The development lowers operational costs and facilitates field-based genetic testing in resource-limited settings. |
| 22 July 2025 | Thermo Fisher Scientific | Thermo Fisher launched a next-generation liquid enzyme formulation optimized for NGS library preparation and clinical-diagnostic applications. | The innovation improves nucleic acid yields by 20% compared to traditional formulations in complex biological samples. |
| 18 May 2025 | Qiagen N.V. | The company announced a strategic partnership to integrate its Proteinase K reagents into integrated point-of-care (POC) diagnostic platforms. | This collaboration accelerates the decentralization of molecular testing for infectious diseases like Tuberculosis and COVID-19. |
| 04 March 2025 | New England Biolabs | NEB commissioned a new cGMP-grade production facility to scale up the manufacturing of animal-free recombinant Proteinase K. | The expansion secures the supply chain for pharmaceutical manufacturers requiring high-grade enzymes for vaccine development. |
Proteinase K Market Scope: Inquire before buying
| Proteinase K Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 112.28 USD Mn |
| Forecast Period 2026-2032 CAGR: | 7.6% | Market Size in 2032: | 187.49 USD Mn |
| Segments Covered: | by Form | Lyophilized Powder Form Liquid Form |
|
| by Application | Isolation & Purification of Genomic DNA & RNA In Situ Hybridization Mitochondria Isolation |
||
| by Therapeutic Area | Isolation & Purification of Genomic DNA & Infectious Diseases Diabetes Oncology Cardiology Nephrology Autoimmune Diseases Neurology Others |
||
Proteinase K Market Regional Insights
North America dominated the proteinase k market with a revenue of $xx Mn in 2025. The increasing spread of cancer in this region has led to an increase in the applications of Next Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) techniques. The reagents such as Proteinase k and other enzymes are required for the performance of these techniques which drive the market upwards. APAC is estimated to be the fastest-growing region with a CAGR of xx% in the forecast period. The developments in targeted therapies are expected to drive the market in this region. Asia accounted for about 30% of COVID-19 cases in the world, which elevated the market growth as proteinase k was useful in the diagnosis of coronavirus.
Key Players / Competitors Profiles Covered in Brief in Global Proteinase K Market Report in Strategic Perspective:
- Thermo Fisher Scientific
- Merck KGaA
- Qiagen N.V.
- F. Hoffmann-La Roche Ltd
- Worthington Biochemical Corporation
- Norgen Biotek Corp
- BIORON GmbH
- Sisco Research Laboratories Pvt Ltd
- Bioline (Meridian Bioscience)
- Promega Corporation
- Codexis
- New England Biolabs
- Takara Bio
- Bio-Rad Laboratories
- Agilent Technologies
- Abcam plc
- GenScript Biotech
- Enzo Life Sciences
- PerkinElmer
- Bio-Techne
- Miltenyi Biotec
- Sartorius AG
- ACROBiosystems
- Canvax Biotech
- G-Biosciences